Skip to main content

Table 1 Baseline characteristics of subjects included in the analysis

From: Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial

 

Group 1

Group 2

Group 3

Group 4

Group 5

Group 6

Number of participants (n = 39)

10

9

5

5

5

5

Sex

 Male

3 (30%)

2 (22%)

2 (40%)

3 (60%)

2 (40%)

5 (100%)

 Female

7 (70%)

7 (78%)

3 (60%)

2 (40%)

3 (60%)

0 (0%)

Age, years

21.5 (1.8)

21.1 (2.6)

22.4 (1.6)

20.1 (1.3)

20.4 (2.5)

22.6 (3.1)

Body mass index, kg/m2

21.8 (2.3)

21.4 (1.7)

22.0 (3.1)

20.6 (2.0)

24.8 (3.3)

23.2 (1.7)

P. falciparum strain

 Immunization

NF54

NF54

NF54

Uninfected

Uninfected

Uninfected

 Challenge

NF135.C10

NF166.C8

NF54

NF135.C10

NF166.C8

NF54

  1. Data are n (%), mean (SD)